The Institute of Molecular and Cell Biology (IMCB) was established in 1987 at the National University of Singapore and later became an autonomous research institute of the Agency for Science, Technology and Research (A*STAR). Its mission is to develop and foster a vibrant research culture for cutting-edge basic biomedical sciences and for training high quality PhDs students for the flourishing biotechnology and pharmaceutical industries in Singapore.
Funded primarily by the Biomedical Research Council (BMRC) of A*STAR, IMCB now has 35 research labs and 8 core facility units consisting of more than 400 research scientists. The IMCB has a highly interactive research environment with state–of-the-art laboratories and core facilities. IMCB’s research activities focus on six major fields: Cell Biology, Developmental Biology, Structural Biology, Infectious Diseases, Cancer Biology and Translational Research with core strengths in cell cycling, cell signalling, cell death, cell motility and protein trafficking.
In end June 2004, IMCB moved to Biopolis from the Medical Drive building to join the other 4 BMRC research institutes. The Biopolis is envisioned as the biggest Biomedical Sciences R&D hub in Asia. IMCB continues to strive for excellence in biomedical R&D, aiming to make Singapore a world-class focus for Biomedical Sciences in Asia and beyond.